Carter Todd Alfred (CIK 0001944011)

Latest company ownership

VYGR - Voyager Therapeutics, Inc.
Role: Chief Scientific Officer
Shares held
92,000
Last filed at
Feb 24, 2025
Confidence Score
50.2
2025Q4
Confidence Score History
2022Q4 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Feb 20, 2025 Feb 24, 2025 Voyager Therapeutics, Inc. Chief Scientific Officer Sell 91.3 +42,695 52.69% ✗ $14.1K
Feb 11, 2025 Feb 12, 2025 Voyager Therapeutics, Inc. Chief Scientific Officer Sell 46.3 -5,413 -6.26% ✗ $24.1K
Jan 14, 2025 Jan 15, 2025 Voyager Therapeutics, Inc. Chief Scientific Officer Sell 27.5 -1,191 -1.36% ✗ $6.1K
Feb 20, 2024 Feb 22, 2024 Voyager Therapeutics, Inc. Chief Scientific Officer Sell 46.3 -3,967 -4.33% ✗ $29.8K
Jan 17, 2024 Jan 19, 2024 Voyager Therapeutics, Inc. Chief Scientific Officer Sell 47.5 -1,266 -2.33% ✗ $9.1K
Sep 15, 2023 Sep 18, 2023 Voyager Therapeutics, Inc. Chief Scientific Officer Sell 20.0 -10,500 -16.19% ✓ $85.7K
Jul 6, 2023 Jul 10, 2023 Voyager Therapeutics, Inc. Chief Scientific Officer Sell 28.8 -5,500 -8.41% ✓ $59.4K
Jun 30, 2023 Jul 5, 2023 Voyager Therapeutics, Inc. Chief Scientific Officer Sell 32.5 -5,000 -7.11% ✓ $57.1K
Mar 20, 2023 Mar 22, 2023 Voyager Therapeutics, Inc. Chief Scientific Officer Sell 41.3 -2,193 -3.25% ✓ $17K
Feb 17, 2023 Feb 22, 2023 Voyager Therapeutics, Inc. Chief Scientific Officer Sell 90.0 +33,262 97.00% ✓ $5.5K
Feb 13, 2023 Feb 15, 2023 Voyager Therapeutics, Inc. Chief Scientific Officer Sell 46.3 -797 -2.27% ✓ $6.1K
Jan 17, 2023 Jan 19, 2023 Voyager Therapeutics, Inc. Chief Scientific Officer Sell 41.3 -1,106 -3.06% ✓ $10.9K
Dec 31, 2022 Jan 10, 2023 Voyager Therapeutics, Inc. Chief Scientific Officer Sell 52.5 - 0.00% ✗ $2.5K